CTCA Chicago, part of City of Hope — Zion, Illinois

CTCA Chicago, part of City of Hope is a clinical research site located in Zion, Illinois, United States 60099.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

CTCA Chicago, part of City of Hope has participated in 1 clinical trials.

Therapeutic areas: RAS Mutation, NRAS Gene Mutation, Melanoma.

Sponsors: OnKure, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CTCA Chicago, part of City of Hope?

CTCA Chicago, part of City of Hope has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CTCA Chicago, part of City of Hope conducted?

CTCA Chicago, part of City of Hope has 1 clinical trials on record. Their work covers RAS Mutation, NRAS Gene Mutation, Melanoma.

Is CTCA Chicago, part of City of Hope accredited by Crixeo Health?

CTCA Chicago, part of City of Hope has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CTCA Chicago, part of City of Hope?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.